The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.
Read Article
New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer
Read Article
Two early phase trials testing the safety and tolerability of new medications may help people with sarcomas, lymphomas and other cancers.
Read Article
Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy
Read Article
Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.
Read Article
Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.
Read Article
"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.
Read Article
May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.
Read Article
Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.
Read Article
Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.
Read Article
A new phase I clinical trial available at Providence Cancer Institute of Oregon will evaluate the efficacy of new immunotherapy designed to modulate the immune system in blood cancer patients.
Read Article
Clinical studies focus on finding new ways to treat colorectal cancer, prevent recurrence and improve survival outcomes.
Read Article
People with gallbladder cancer, bile duct cancer or pancreatic cancer may be eligible to participate in new clinical trials available at Providence Cancer Institute of Oregon.
Read Article
Researchers at Providence Cancer Institute are studying how well two surgical procedures work in reducing the risk of ovarian cancer for women with BRCA1 mutations.
Read Article
A new study at Providence Cancer Institute tests the effectiveness of an experimental treatment and chemotherapy to inhibit tumor growth in people with lung cancer.
Read Article
Providence Cancer Institute breast cancer experts are researching new treatments for women with triple-negative breast cancer and HER-2 positive breast cancer.
Read Article
Experts in biomedical engineering, immunology and surgical oncology are working collaboratively to improve outcomes for people with head, neck and other cancers.
Read Article
Providence Cancer Institute to open new clinical study of CAR T-cell therapy to people with clear cell renal cell carcinoma, the most common type of kidney cancer.
Read Article
First-in-human immune therapy study at Providence Cancer Institute will assess the safety and effectiveness of talquetamab as a potential treatment for cancerous plasma cells known as multiple myeloma
Read Article
Providence researchers awarded funding from National Cancer Institute to study “Bugs as Drugs.”
Read Article
Loading More...
